Aurora Cannabis (ACB) Free Cash Flow (2010 - 2026)
Aurora Cannabis (ACB) free cash flow from Dec 31, 2010 to Mar 31, 2026. The TTM Aurora Cannabis (ACB) free cash flow is -$26M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Free Cash Flow
Quarterly Free Cash Flow
Aurora Cannabis (ACB) Free Cash Flow CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +714.26% |
| 3 Years TTM | -40.45% |
| 5 Years TTM | -37.59% |
| 10 Years TTM | +12.26% |
| All Time TTM | +43.46% |
Annual Free Cash Flow change of Aurora Cannabis (ACB)
| Year | Free Cash Flow | Change |
|---|---|---|
| 2026 | -$26M | +1208.07% |
| 2025 | -$1.98M | -96.86% |
| 2024 | -$63M | -33.43% |
| 2023 | -$95M | -16.89% |
| 2022 | -$114M | -45.72% |
| 2021 | -$210M | -57.19% |
| 2020 | -$490M | +7.95% |
| 2019 | -$454M | +167.78% |
| 2018 | -$170M | +477.77% |
| 2017 | -$29M | +340.14% |
| 2016 | -$6.67M | -24.16% |
| 2015 | -$8.80M | -12.57% |
| 2014 | -$10M | +2172.46% |
| 2013 | -$443K | +56.59% |
| 2012 | -$283K | -25.91% |
| 2011 | -$382K | +661.21% |
| 2010 | -$50K | N/A |
Comparison Aurora Cannabis (ACB) five years free cash flow CAGR with competitors
Aurora Cannabis (ACB) five years free cash flow CAGR is -37.59%.
| Ticker | Name | five years Free Cash Flow CAGR | Upside |
|---|---|---|---|
| LNTH | Lantheus Holdings Inc | 89.22% | -337.35% |
| ORGO | Organogenesis Holdings Inc - Class A | 87.05% | -331.57% |
| PRFX | PRF Technologies Ltd | 60.45% | -260.81% |
| HROW | Harrow Inc | 51.26% | -236.37% |
| SBFM | Sunshine Biopharma Inc | 46.84% | -224.60% |
| ANIP | ANI Pharmaceuticals Inc | 45.89% | -222.07% |
| ALKS | Alkermes plc | 36.06% | -195.94% |
| PCRX | Pacira BioSciences Inc | 27.91% | -174.25% |
| ALVO | Alvotech | 26.48% | -170.44% |
| NBIX | Neurocrine Biosciences Inc | 25.83% | -168.72% |
| AMPH | Amphastar Pharmaceuticals Inc | 24.53% | -165.24% |
| COLL | Collegium Pharmaceutical Inc | 23.23% | -161.81% |
| CRDL | Cardiol Therapeutics Inc - Class A | 20.58% | -154.74% |
| UTHR | United Therapeutics Corp | 12.12% | -132.23% |
| PAHC | Phibro Animal Health Corp - Class A | 6.13% | -116.31% |
| ZTS | Zoetis Inc - Class A | 4.90% | -113.02% |
| PBH | Prestige Consumer Healthcare Inc | 2.93% | -107.78% |
| HCM | HUTCHMED (China) Ltd | 2.39% | -106.37% |
| INM | InMed Pharmaceuticals Inc | 1.61% | -104.27% |
| EOLS | Evolus Inc | 0.82% | -102.19% |
| BHC | Bausch Health Companies Inc | 0.61% | -101.63% |